STUDYID,USUBJID,SUBJID,SITEID,SITESUBJ,AGE,AGEU,AGEGR1,SEX,CHILDPOT,RACE,ETHNIC,SAFFL,DLTEVLFL,PKEVLFL,ENRLFL,ARM,ARMCD,ACTARMCD,ACTARM,TRT01P,TRT01PN,TRTSDT,TRTSTM,TRTSDTM,TRTEDT,TRTETM,TRTEDTM,EOSSTT,EOSDT,DCSREAS,DCSREASP,EOTSTT,EOTDT,DCTREAS,DCTREASP,DCTRSNB,DCTRNBSP,RFICDT,ICWTHDT,PROGDT,FRBSWDT,ETTBWDT,ETTB,FRBS,PSCRNFAL,LSTALVDT,FUPCTDT,DTHDT,EOTFUFL,WEIGHTBL,HEIGHTBL,BMIBL,BSABL,ECOGBL,TRT01AN,TRT01A
043-18101,043-18101-74001-001,74001-001,74001,74001-74001-001,74,YEARS,>= 65,M,,WHITE,NOT REPORTED,Y,N,Y,Y,AIRIS-101 1,AIRIS1,AIRIS1,AIRIS-101 1,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 100 mg/m^2,1,08MAY19,9:23,08MAY19:09:23:00,19MAY19,,,DISCONTINUED,22MAY2019,WITHDRAWAL BY PATIENT FROM STUDY,,DISCONTINUED,22MAY2019,ADVERSE EVENT,,ADVERSE EVENT,,02MAY19,22MAY2019,,,,Y,Y,N,22MAY2019,,,N,94.347136,172.72,31.625941453,2.08,1,1,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 100 mg/m^2
043-18101,043-18101-74001-002,74001-002,74001,74001-74001-002,44,YEARS,< 65,M,,OTHER,HISPANIC OR LATINO,Y,N,Y,Y,AIRIS-101 1,AIRIS1,AIRIS1,AIRIS-101 1,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 100 mg/m^2,1,15MAY19,9:22,15MAY19:09:22:00,26MAY19,,,DISCONTINUED,05SEP2019,DEATH,,DISCONTINUED,29MAY2019,OTHER,PHYSICIAN'S DECISION,OTHER,PHYSICIAN'S DECISION,06MAY19,,06AUG2019,,,Y,Y,N,05SEP2019,05SEP2019,05SEP19,N,89.5390608,175.26,29.150561187,2.05,1,1,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 100 mg/m^2
043-18101,043-18101-74001-003,74001-003,74001,74001-74001-003,80,YEARS,>= 65,M,,WHITE,NOT HISPANIC OR LATINO,Y,N,Y,Y,AIRIS-101 1,AIRIS1,AIRIS1,AIRIS-101 1,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 100 mg/m^2,1,15MAY19,9:54,15MAY19:09:54:00,17MAY19,,,DISCONTINUED,26MAY2019,DEATH,,DISCONTINUED,20MAY2019,ADVERSE EVENT,,ADVERSE EVENT,,07MAY19,,,,,Y,Y,N,26MAY2019,,26MAY19,N,67.3130528,167.64,23.952121329,1.76,1,1,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 100 mg/m^2
043-18101,043-18101-74001-004,74001-004,74001,74001-74001-004,54,YEARS,< 65,F,N,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Y,Y,Y,Y,AIRIS-101 1A,AIRIS1A,AIRIS1A,AIRIS-101 1A,AIRIS-101 80 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,2,13SEP19,9:56,13SEP19:09:56:00,22NOV19,,,ONGOING,,,,DISCONTINUED,06DEC2019,RADIOLOGICAL PROGRESSION,,RADIOLOGICAL PROGRESSION,,10SEP19,,,,,Y,Y,N,31JAN2020,,,Y,100.697424,162.56,38.10579086,2.04,1,2,AIRIS-101 80 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74001-005,74001-005,74001,74001-74001-005,48,YEARS,< 65,F,N,WHITE,HISPANIC OR LATINO,Y,Y,Y,Y,AIRIS-101 2A,AIRIS2A,AIRIS2A,AIRIS-101 2A,AIRIS-101 160 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,3,19DEC19,10:25,19DEC19:10:25:00,,,,ONGOING,,,,ONGOING,,,,,,22NOV19,,,,,Y,Y,N,02MAR2020,,,N,88.7225952,165.1,32.549182864,1.96,1,3,AIRIS-101 160 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74001-006,74001-006,74001,74001-74001-006,68,YEARS,>= 65,M,,WHITE,HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,03MAR20,,,03MAR20,,N,Y,N,03MAR2020,,,N,,,,,,,
043-18101,043-18101-74002-001,74002-001,74002,74002-74002-001,49,YEARS,< 65,F,N,ASIAN,NOT HISPANIC OR LATINO,Y,Y,Y,Y,AIRIS-101 1A,AIRIS1A,AIRIS1A,AIRIS-101 1A,AIRIS-101 80 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,2,07NOV19,9:24,07NOV19:09:24:00,23DEC19,,,DISCONTINUED,10FEB2020,DEATH,,DISCONTINUED,15JAN2020,CLINICAL PROGRESSION,,CLINICAL PROGRESSION,,24OCT19,,,,,N,Y,N,10FEB2020,,10FEB20,N,41.5490272,152.4,17.889200267,1.34,0,2,AIRIS-101 80 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74002-002,74002-002,74002,74002-74002-002,66,YEARS,>= 65,F,N,WHITE,NOT HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,18NOV19,,,,,Y,Y,Y,18NOV2019,,,N,,,,,,,
043-18101,043-18101-74003-001,74003-001,74003,74003-74003-001,55,YEARS,< 65,F,N,OTHER,HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,17SEP19,,,,,Y,Y,N,17SEP2019,,,N,,,,,,,
043-18101,043-18101-74003-002,74003-002,74003,74003-74003-002,51,YEARS,< 65,F,N,UNKNOWN,NOT HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,07OCT19,,,,,N,Y,N,07OCT2019,,,N,,,,,,,
043-18101,043-18101-74003-003,74003-003,74003,74003-74003-003,63,YEARS,< 65,F,N,UNKNOWN,NOT HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,16OCT19,,,,,Y,Y,N,23OCT2019,,,N,,,,,,,
043-18101,043-18101-74003-004,74003-004,74003,74003-74003-004,54,YEARS,< 65,F,N,WHITE,NOT HISPANIC OR LATINO,Y,Y,Y,Y,AIRIS-101 1A,AIRIS1A,AIRIS1A,AIRIS-101 1A,AIRIS-101 80 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,2,07NOV19,12:45,07NOV19:12:45:00,12JAN20,,,DISCONTINUED,12FEB2020,WITHDRAWAL BY PATIENT FROM STUDY,,DISCONTINUED,15JAN2020,RADIOLOGICAL PROGRESSION,,RADIOLOGICAL PROGRESSION,,30OCT19,12FEB2020,,,,Y,Y,N,12FEB2020,,,N,57.2,172.8,19.156164266,,1,2,AIRIS-101 80 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74003-005,74003-005,74003,74003-74003-005,61,YEARS,< 65,F,N,WHITE,NOT HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,12NOV19,,,,,N,N,N,12NOV2019,,,N,,,,,,,
043-18101,043-18101-74003-006,74003-006,74003,74003-74003-006,49,YEARS,< 65,M,,WHITE,NOT HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,10DEC19,,,,,N,Y,N,13DEC2019,,,N,,,,,,,
043-18101,043-18101-74003-007,74003-007,74003,74003-74003-007,56,YEARS,< 65,M,,WHITE,NOT HISPANIC OR LATINO,Y,N,Y,Y,AIRIS-101 3A,AIRIS3A,AIRIS3A,AIRIS-101 3A,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,4,19MAR20,12:48,19MAR20:12:48:00,,,,ONGOING,,,,ONGOING,,,,,,20FEB20,,,,,N,N,N,19MAR2020,,,N,89.2,198,22.752780329,,0,4,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74004-001,74004-001,74004,74004-74004-001,61,YEARS,< 65,M,,WHITE,NOT HISPANIC OR LATINO,N,N,N,N,Screen Failure,SCRNFAIL,SCRNFAIL,Screen Failure,,,,,,,,,ONGOING,,,,ONGOING,,,,,,23OCT19,,,,,N,Y,N,23OCT2019,,,N,,,,,,,
043-18101,043-18101-74004-002,74004-002,74004,74004-74004-002,78,YEARS,>= 65,M,,WHITE,NOT HISPANIC OR LATINO,Y,Y,Y,Y,AIRIS-101 2A,AIRIS2A,AIRIS2A,AIRIS-101 2A,AIRIS-101 160 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,3,06JAN20,13:04,06JAN20:13:04:00,22FEB20,,,DISCONTINUED,27FEB2020,WITHDRAWAL BY PATIENT FROM STUDY,,DISCONTINUED,27FEB2020,CLINICAL PROGRESSION,,CLINICAL PROGRESSION,,17DEC19,27FEB2020,,,,N,Y,N,27FEB2020,,,N,70.3,176,22.694989669,1.85,1,3,AIRIS-101 160 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74004-003,74004-003,74004,74004-74004-003,46,YEARS,< 65,M,,WHITE,NOT HISPANIC OR LATINO,Y,Y,Y,Y,AIRIS-101 2A,AIRIS2A,AIRIS2A,AIRIS-101 2A,AIRIS-101 160 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,3,27JAN20,11:30,27JAN20:11:30:00,12FEB20,,,ONGOING,,,,DISCONTINUED,25FEB2020,CLINICAL PROGRESSION,,CLINICAL PROGRESSION,,13JAN20,,,,,N,Y,N,25FEB2020,,,N,112.9,181,34.461707518,2.4,1,3,AIRIS-101 160 mg QD Intermittent + nab-paclitaxel 75 mg/m^2
043-18101,043-18101-74004-004,74004-004,74004,74004-74004-004,44,YEARS,< 65,F,Y,ASIAN,NOT HISPANIC OR LATINO,Y,N,Y,Y,AIRIS-101 3A,AIRIS3A,AIRIS3A,AIRIS-101 3A,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 75 mg/m^2,4,16MAR20,11:30,16MAR20:11:30:00,,,,ONGOING,,,,ONGOING,,,,,,03MAR20,,,,,N,Y,N,23MAR2020,,,N,59.1,159,23.377239824,1.62,0,4,AIRIS-101 240 mg QD Intermittent + nab-paclitaxel 75 mg/m^2